<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="999">
  <stage>Registered</stage>
  <submitdate>16/01/2006</submitdate>
  <approvaldate>19/01/2006</approvaldate>
  <actrnumber>ACTRN12606000024549</actrnumber>
  <trial_identification>
    <studytitle>Randomised placebo controlled trial on the safety and efficacy of Biolane in osteoarthritis</studytitle>
    <scientifictitle>Randomised placebo controlled trial on the safety and efficacy of Biolane in osteoarthritis of the knees and/or hips</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>Osteoarthritis of the knees and/or hips</healthcondition>
    <conditioncode>
      <conditioncode1>Musculoskeletal</conditioncode1>
      <conditioncode2>Osteoarthritis</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Biolane  for a period of 18 weeks</interventions>
    <comparator>placebo</comparator>
    <control>Placebo</control>
    <interventioncode>Treatment: Other</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Clinical outcomes will be assessed using the Western Ontario and McMaster Universities (WOMAC) OA index.</outcome>
      <timepoint>WOMAC is measured at baseline and weeks 6, 12 and 18.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Comprehensive Osteoarthritis Test (COAT) and Short Form-36.</outcome>
      <timepoint>At baseline and weeks 6, 12 and 18.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Blood safety measures</outcome>
      <timepoint>At baseline and weeks 12 and 18.</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Laboratory assays to assess fibrinolysis, coagulation, inflammation, cartilage synthesis and degradation and bone formation and resorption.</outcome>
      <timepoint>At baseline and weeks 12 and 18.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Total WOMAC score of &gt;30 at baseline-x-ray and clinical evidence of osteoarthritis of the knees and/or hips.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>75</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Gout, rheumatoid arthritis or other inflammatory joint condition-Allergy to seafood or gelatine-Use of monoamine oxidase inhibitors-Use of corticosteroids within 4 weeks prior to baseline and throughout the study-Use of aspirin or anti-inflammatory agents 3 weeks prior to baseline and for the duration of the study-Use of complementary anti-arthritic medicines 6 weeks prior to baseline and for the duration of the study-Liver function tests greater then 3 times the upper limit of normal at baseline.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>Study medications supplied in numbered containers by the sponsor</concealment>
    <sequence>Computer generated block randomisation scheme</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Safety/efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 2 / Phase 3</phase>
    <anticipatedstartdate>30/01/2006</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>100</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Commercial sector/Industry</primarysponsortype>
    <primarysponsorname>Healtheries of New Zealand Ltd</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry>New Zealand</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Commercial sector/Industry</fundingtype>
      <fundingname>Healtheries of New Zealand Ltd</fundingname>
      <fundingaddress />
      <fundingcountry>New Zealand</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname>N/A</sponsorname>
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary />
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Australian Centre for Complementary Medicine Education and Research, Mater Health Services</ethicname>
      <ethicaddress>South Brisbane, QLD</ethicaddress>
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Dr Phillip Cheras</name>
      <address>Australian Centre for Complementary Medicine Education and Research (ACCMER)
Level 2
Community Services Building
Mater Health Services
South Brisbane QLD 4101</address>
      <phone>+61 7 38406120</phone>
      <fax>+61 7 38406119</fax>
      <email>p.cheras@uq.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Trudi Cattley</name>
      <address>Australian Centre for Complementary Medicine Education and Research (ACCMER)
Level 2
Community Services Building
Mater Health Services
South Brisbane QLD 4101</address>
      <phone>+61 7 30103311</phone>
      <fax>+61 7 38406119</fax>
      <email>t.cattley@uq.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>